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Purpose: Traditionally, an interval of 4 to 6 weeks has been recommended after prostate 
biopsy before open radical prostatectomy. However, such an interval is not explicitly 
specified in robot-assisted laparoscopic radical prostatectomy (RALP). This study was 
designed to determine whether the interval from prostate biopsy to RALP affects surgi-
cal difficulties. 
Materials and Methods: Between January 2008 and May 2009, a total of 237 men under-
went RALP in our institution. The interval from biopsy to RALP was categorized as fol-
lows: ≤  2 weeks, ＞2 to ≤  4 weeks, ＞4 to ≤  6 weeks, ＞6 to ≤  8 weeks, and ＞8 weeks. 
Multivariate analysis was used to identify whether the interval from prostate biopsy 
to RALP was an independent predictor of operative time, estimated blood loss (EBL), 
margin positivity, continence, and potency.
Results: Among the 5 groups, there were no significant differences in age, body mass 
index (BMI), preoperative serum prostate-specific antigen (PSA), prostate volume, or 
preoperative International Index of Erectile Dysfunction-5 score (all p＞0.05). In the 
multivariate analysis, operative time was significantly associated with prostate 
volume. EBL was associated with prostate volume and BMI. Margin positivity was as-
sociated with preoperative serum PSA, prostate volume, and biopsy Gleason score. 
Postoperative continence and potency were significantly associated with age. However, 
in univariate and multivariate analyses, the interval from biopsy to RALP was not sig-
nificantly associated with operative time, EBL, margin positivity, postoperative con-
tinence, or potency (all p＞0.05). 
Conclusions: Our data suggest that the interval from prostate biopsy to RALP is not 
related to surgical difficulties. 
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INTRODUCTION
Prostate cancer is the most prevalent type of cancer in 
American men. In Korea, its rate of incidence has increased 
20 times over the past two decades, which has motivated 
continuous efforts for the early diagnosis and complete 
treatment of prostate cancer. Prostate cancer can be cured 
through radical prostatectomy when the cancer is in the 
early stage of development and thus confined to the 
prostate. Radical prostatectomy is currently the most prev-
alent treatment option for prostate cancer. Prostate cancer 
is diagnosed through a prostate biopsy. Traditionally, an 
interval of 4 to 6 weeks has been recommended after trans-
rectal prostate needle biopsy before open radical prostatec-
tomy, because the hematoma or inflammatory reactions 
caused by the biopsy may interrupt determination of surgi-
cal planes during the surgery. This guideline, however, is 
not explicitly specified in cases of robot-assisted laparo-Korean J Urol 2011;52:664-668
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TABLE 1. Clinicopathological characteristics classified by interval from biopsy to RALP
Interval from biopsy to RALP 
p-value 
≤2 wk 3-4 wk 5-6 wk 6-8 wk ＞8 wk
Age (yr)
BMI (kg/m
2)
PSA (ng/ml)
Prostate volume (cc)
IIEF-5
Biopsy Gleason score
　
　
　
Clinical stage
　
　
　
　
　
　
　
　
6
7
≥8
　
T1c
≥T2
63.0±7.2 
24.8±2.3 
16.0±17.3 
35.6±12.1 
18.3±6.0 
　
13
8
7
　
15
13
64.8±7.5 
24.5±2.3 
11.9±11.4 
37.8±12.5 
18.7±5.6 
　
38
26
10
　
45
29
65.9±6.1 
24.3±3.0 
15.8±36.3 
35.4±13.2 
17.6±3.4 
　
30
21
8
　
41
18
64.5±5.2 
24.1±2.4 
9.1±7.9 
30.8±8.4 
20.0±3.8 
　
10
6
4
　
13
7
67.3±6.3 
25.1±3.0 
14.4±15.8 
42.3±20.0 
15.7±5.9 
　
12
8
1
　
15
6
0.232
0.706
0.701
0.067
0.595
0.291
　
　
　
0.147
　
RALP: robot-assisted laparoscopic radical prostatectomy, BMI: body mass index, PSA: prostate-specific antigen, IIEF-5: International 
Index of Erectile Function-5
scopic radical prostatectomy (RALP). This study was de-
signed to determine whether the interval from prostate bi-
opsy to RALP affects surgical difficulties. 
MATERIALS AND METHODS
1. Materials
For this study, 202 patients were selected from a group of 
237 patients who underwent RALP from January 2008 to 
May 2009; patients who underwent hormonal therapy be-
fore the surgery, those whose medical records about the 
time of biopsy were missing, and those who underwent pel-
vic surgery in the past were excluded. The medical records 
and pathological reports of the patients were analyzed 
retrospectively. Postoperative urinary continence and re-
covery of erectile function were analyzed by using the data 
for the 68 patients who had been observed for more than 
1 year in the follow-up period.
2. Methods
The interval between the prostate biopsy and RALP was 
categorized into five groups as follows: within 2 weeks (28 
patients), 2 to 4 weeks (74 patients), 4 to 6 weeks (59 pa-
tients), 6 to 8 weeks (20 patients), and beyond 8 weeks (21 
patients). Univariate and multivariate statistical analy-
ses were performed to verify whether the interval between 
biopsy and surgery had any effect on the duration of sur-
gery, estimated blood loss, positive margin rate, post-
operative urinary continence, or recovery of erectile 
function. We classified our data into two categories; the cut-
off points were an operative time of 140 minutes and esti-
mated blood loss of 100 cc, separately. Urinary continence 
was defined as the cessation of urinary leaks or no use of 
a pad at 6 months after the surgery, and potency was de-
fined as successful vaginal penetration.
3. Statistical analysis
Statistical analysis was done with  SPSS ver. 17 (SPSS Inc., 
Chicago, IL, USA). Differences in demographics and clin-
ical and pathological factors were examined by using the 
Kruskal-Wallis test and chi-square test for continuous and 
categorical variables, respectively. Logistic regression was 
used for univariate and multivariate analyses. A p-value 
less than 0.05 was considered to be statistically significant.
RESULTS
No significant differences were found between the catego-
ries in age, body mass index (BMI), preoperative pros-
tate-specific antigen (PSA), prostate volume , preoperative 
International Index of Erectile Function-5 score, Gleason 
score, or clinical stage (all p＞0.05) (Table 1) after the trans-
rectal ultrasound biopsy.
　Univariate analysis revealed that BMI (p=0.045, p
＜0.001) and prostate volume (all p＜0.001) were asso-
ciated with operative time and estimated blood loss. 
Positive margin status was correlated with preoperative 
PSA (p=0.002), prostate volume (p=0.006), and biopsy 
Gleason score (p=0.005). Postoperative urinary continence 
and potency showed statistically significant correlations 
with age (p=0.027, p=0.002).
　In the multivariate analysis, operative time was sig-
nificantly associated with prostate volume (p＜0.001). 
Estimated blood loss was associated with prostate volume 
(p＜0.001) and BMI (p=0.033). Margin status was asso-
ciated with preoperative serum PSA (p=0.049), prostate 
volume (p=0.005), and biopsy Gleason score (p = 0.034) (See 
Table 2). Postoperative continence and potency were sig-
nificantly associated with age (p=0.023, p=0.007) (Tables 
3,4). Both the univariate and multivariate analyses, how-
ever, failed to show that the interval from biopsy to surgery 
had any significant relations with surgery time, blood loss, 
positive margin rate, postoperative urinary continence, or Korean J Urol 2011;52:664-668
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TABLE 2. Multivariate logistic regression analysis of the predictive factors of operative time, blood loss, and margin status
Operative time Blood loss Margin status
Odds ratio p-value Odds ratio p-value Odds ratio p-value
Age 
BMI 
Preoperative PSA 
Prostate volume 
Clinical tumor stage
 (≥T2 vs T1) 
Biopsy Gleason score (vs. 6) 
Interval from biopsy to RALP 
　
Referent 
Overweight
Obese 
7
≥8
Referent 
＞2 wks to ≤4 wks 
＞4 wks to ≤6 wks 
＞6 wks to ≤8 wks 
＞8 wks 
0.964
1.323
1.221
0.995
1.149
0.93
1.909
2.552
1.311
1.512
3.56
2.011
0.227
0.801
0.505
0.763
0.684
＜0.001
0.856
0.174
0.114
0.114
0.439
0.637
0.489
0.081
0.363
0.959
1.870
5.095
1.003
1.087
0.745
1.044
1.900
0.808
0.893
1.206
1.771
0.125
0.033
0.123
0.010
0.729
＜0.001
0.433
0.465
0.909
0.236
0.741
0.675
0.832
0.783
0.408
0.989
1.088
2.678
2.554
0.958
0.744
1.569
3.017
1.010
0.722
1.199
2.513
0.689
0.208
0.828
0.096
0.049
0.005
0.419
0.101
0.237
0.034
0.339
0.984
0.535
0.780
0.168
BMI: body mass index, PSA: prostate-specific antigen, RALP: robot-assisted laparoscopic radical prostatectomy
TABLE 3. Multivariate logistic regression analysis of the predictive factors of postoperative continence
Odds ratio  95% CI p-value 
Age 
BMI 
Preoperative PSA 
Prostate volume 
Clinical tumor stage (≥T2 vs T1) 
Biopsy Gleason score (≥7 vs 6) 
IIEF-5 score 
Presence of relevant comorbidity 
Interval from biopsy to RALP 
Referent 
Overweight 
Obese 
Referent 
＞2 to ≤4 wk
＞4 to ≤6 wk
＞6 to ≤8 wk
＞8 wk
0.696
0.436
1.047
1.322
1.07
0.531
1.515
8.475
0.000
0.000
0.000
1.145
0.509-0.951
0.047-4.021
-
0.954-1.833
0.919-1.247
0.049-5.804
0.128-17.905
0.162-443.686
-
-
-
-
0.023
0.765
0.464
0.999
0.093
0.384
0.604
0.558
0.742
0.29
0.517
0.999
0.999
0.999
1.000
CI: confidence interval, BMI: body mass index, PSA: prostate-specific antigen, IIEF-5: International Index of Erectile Function-5, RALP: 
robot-assisted laparoscopic radical prostatectomy
potency (all p＞0.05).
DISCUSSION
Recently, nearly all prostate cancer cases are diagnosed 
through a transrectal prostate biopsy. The mean number 
of removed cores increased from 6.9 to 10.2 in the past dec-
ade, and it is highly advised that open radical prostatec-
tomy be executed in about 4 to 6 weeks after a prostate 
biopsy. This is because the hematoma or inflammatory re-
actions caused by a biopsy may interrupt the determi-
nation of the surgical planes in the prostatectomy [1,2]. 
Transrectal prostate biopsy can cause inflammatory re-
actions, bleeding, hematoma, and other reactions around 
the prostate. Ikonen et al reported that a transrectal mag-
netic resonance imaging executed after a prostate biopsy 
revealed bleeding in 77% of the patients, and the total 
bleeding amount evidently decreased only after a lapse of 
28 days since the biopsy [3].
　A fair number of studies have been carried out on surgical 
outcomes compared according to the interval from prostate 
biopsy to surgery. Among them, Lee et al compared the surgi-
cal outcome and the postoperative recovery of erectile func-
tion in the category of post-biopsy delay. The outcome of and 
complications associated with the surgery and postopera-
tive continence had no relation to the interval between biop-Korean J Urol 2011;52:664-668
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TABLE 4. Multivariate logistic regression analysis of the predictive factors of postoperative potency
Odds ratio  95% CI  p-value 
Age 
BMI 
Preoperative PSA 
Prostate volume 
Clinical tumor stage (≥T2 vs T1) 
Biopsy Gleason score (≥7 vs 6) 
Baseline IIEF-5 score 
Presence of relevant comorbidity 
Nerve sparing
Interval from biopsy to RALP 
Referent 
Overweight 
Obese 
Referent 
＞2 to ≤4 wk
＞4 to ≤6 wk
＞6 to ≤8 wk
＞8 wk
0.587
0.399
26.747
0.949
1.001
4.475
0.999
37.022
4.567
0.586
1.74
3.914
2.561
0.398-0.866
0.016-10.024
0.199-3590.274
0.841-1.070
0.853-1.174
0.143-140.064
0.788-1.265
0.668-2051.878
0.010-2081.531
0.004-77.284
0.023-132.737
0.060-253.951
0.039-168.039
0.007
0.322
0.576
0.189
0.391
0.99
0.394
0.174
0.990
0.078
0.627
0.908
0.83
0.802
0.522
0.659
CI: confidence interval, BMI: body mass index, PSA: prostate-specific antigen, IIEF-5: International Index of Erectile Function-5, RALP: 
robot-assisted laparoscopic radical prostatectomy
sy and surgery, but intraoperative blood loss showed sig-
nificant differences. The authors concluded that a shorter 
interval between biopsy and surgery makes the remaining 
inflammatory reactions more severe and thus makes it more 
difficult to determine the surgical planes for prostatectomy, 
leading to more bleeding [4]. In another study, Eggener et 
al analyzed the postoperative outcome according to the in-
terval from prostate biopsy to open radical prostatectomy. 
Their univariate analysis demonstrated that blood loss and 
surgery time increased when the interval between biopsy 
and surgery was short, but a multivariate analysis did not 
reveal any significant differences [5].
　On the other hand, few studies have been done on post-
operative outcomes according to the interval between pros-
tate biopsy and RALP. Martin et al, after analyzing this is-
sue, reported that RALP executed within 6 weeks after bi-
opsy was associated with significantly more cases of sur-
gery-related complications. They also reported that the 
RALP caused less blood loss and was less invasive than was 
open prostatectomy. The interval between biopsy and sur-
gery exerts greater effects on postoperative outcomes be-
cause this surgery is carried out on the basis of visual rather 
than tactile sensations [6]. By contrast, Menon et al and 
Tewari et al demonstrated that the visual assistance pro-
vided by the 3-D display of the RALP could sufficiently com-
pensate for the lack of the tactile feedback of open prosta-
tectomy [7,8]. Similar outcomes were reported by Choi et 
al [9]. In that study, the authors concluded that there is no 
reason to delay RALP to more than 4 weeks after prostate 
biopsy and that RALP is a feasible procedure regardless of 
the biopsy-related prostate state.
　The present study was carried out with 202 patients who 
underwent RALP in our institution. Our results suggest 
that the interval from biopsy to surgery had no significant 
correlations with surgery time, intraoperative blood loss, 
positive margin rate, or postoperative continence and po-
tency. These findings are consistent with the results ob-
tained from the above-mentioned studies on postoperative 
outcomes compared by the interval between prostate biop-
sy and open radical prostatectomy. These results could be 
interpreted to mean that the hematoma and inflammatory 
reactions generated by a prostate biopsy cause no sig-
nificant differences in the postoperative outcome even 
though they make it difficult to determine the surgical 
planes. Many factors such as the operator's experiences 
and the 3-dimensional visualization of the RALP that com-
pensates for the lack of tactile feedback could explain these 
insignificant differences. Concerning the operator’s expe-
rience, Lee et al reported that operation time and estimated 
blood loss showed a steep learning curve for RALP during 
the early 24 cases and then stabilized [10]. To reach more 
definite conclusions on this issue, more studies are neces-
sary.
　In this study, long-term postoperative outcomes such as 
the rates of biochemical recurrence and tumor-specific sur-
vival were excluded. In a few studies, findings were pre-
sented on the effects that the interval from biopsy to sur-
gery exerted on outcomes observed in a long-term follow-up 
period. Several recent studies reported that the risks of bio-
chemical recurrence and elevated Gleason score were not 
increased even when the interval from biopsy to surgery 
exceeded 5 months [11-13].
　The potential limitations of this study should be ac-
knowledged as a means for improvement or for mapping 
of strategies for further study. Such limitations include the 
fact that there were only a small number of reported cases, 
as well as the retrospective nature of the study and the sus-
ceptibility to bias inherent in such a design. Moreover, the 
duration of follow-up was brief for assessing postoperative 
urinary incontinence and recovery of erectile function. Korean J Urol 2011;52:664-668
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However, in 68 patients who had been observed for more 
than 1 year, many factors that could influence the func-
tional outcomes were well controlled in our analysis. Thus, 
it is unlikely that the equivalent results associated with the 
different intervals from biopsy were an artifact of an im-
balance of the predicting factors. Also, it should not be ig-
nored that the potential for selection bias exists because 
the analysis was based on a group of subjects who under-
went surgery by one surgeon at the same institution. Last, 
the composition of the subject group analyzed in this study 
differed from those used in other studies. In this study, the 
majority of the subject group (161 patients out of 202, 
79.7%) underwent RALP within 6 weeks after prostate 
biopsy. This skewness in the sample may be attributed to 
the short history and limited use of RALP. The biggest rea-
son, however, may be the inclination of the patients to un-
dergo treatment as soon as possible after the diagnosis ow-
ing to fear of prostate cancer. In this respect, further studies 
are recommended with a prospective experimental design 
and in a larger subject group.
CONCLUSIONS
The interval from prostate biopsy to RALP did not show any 
significant correlations with surgery time, intraoperative 
blood loss, positive margin rate, or postoperative con-
tinence and potency. In this respect, post-biopsy delay until 
RALP is not estimated to render any effect on the operative 
difficulties of the surgery. 
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